Su Ann Yeoh

1 BACKGROUND Worldwide, 207,000 women die from ovarian cancer every year,1 with this number projected to increase by 50% by 2040.1 The high mortality rate is a result of absence of disease symptoms leading to the lack of early detection and minimal advances in treatment.2 Consequently, individuals with ovarian cancer often receive diagnoses in advanced disease stages, leading to a 5-year survival rate of 29%2 and a high recurrence rate, currently at 75%.3 This is in contrast to other cancers...